New injection aims to fight devastating weight loss in cancer patients
Symptom relief
Recruiting now
This is an early-stage study to check the safety and find the right dose of an experimental injection called SXRN. It is for adults with advanced cancer who are experiencing severe, unintentional weight loss and loss of appetite, known as cachexia. The study will first test SXRN …
Phase: PHASE1 • Sponsor: Jiangsu Nutai Biologics Co., Ltd • Aim: Symptom relief
Last updated Mar 13, 2026 15:06 UTC